Last Updated: June 24, 2026

List of Excipients in Branded Drug NIGHT TIME SLEEP AID


✉ Email this page to a colleague

« Back to Dashboard


Excipient Strategy and Commercial Opportunities for Night Time Sleep Aids

Last updated: February 27, 2026

What are the key excipient considerations in formulation development for night time sleep aids?

Night time sleep aids often require excipients that promote stability, enhance bioavailability, and support patient compliance. The choice of excipients can influence drug release profile, shelf-life, and non-sedative side effects.

Common excipients used in night time sleep aids:

  • Diluent/bulking agents: Microcrystalline cellulose, lactose, or mannitol provide volume and improve handling.
  • Disintegrants: Croscarmellose sodium or sodium starch glycolate facilitate rapid disintegration for quick onset.
  • Binders: Povidone or hydroxypropyl cellulose (HPC) help in tablet formation.
  • Lubricants: Magnesium stearate reduces tablet sticking during compression.
  • Sweeteners and flavoring agents: Sucralose, flavor enhancers improve palatability.
  • Filling agents for liquids: Glycerol, carboxymethylcellulose serve as vehicle or viscosity modifiers.

Specialized considerations:

  • Sedative reliability: Use of non-active ingredients that do not induce alertness or adverse interactions.
  • Gastroretentive excipients: For sustained-release formulations, excipients like polyethylene oxide can prolong drug release.
  • Taste masking agents: Critical in liquid formulations to ensure patient compliance.

How do excipient choices influence formulation stability, efficacy, and patient compliance?

Stability

  • Excipients like antioxidants (e.g., ascorbic acid) prevent drug degradation.
  • Humectants control moisture to prevent microbial growth and physical changes.

Efficacy

  • Disintegrants ensure rapid onset by facilitating quick drug release.
  • Controlled-release excipients can extend sleep duration without multiple dosing.

Patient compliance

  • Flavoring agents and fillers improve palatability.
  • Tablet size and mass impact swallowing ease; smaller, smoother tablets are preferred.

What commercial opportunities exist within excipient development for night time sleep aids?

Growing market demand

  • The insomnia treatment market reached approximately $4 billion in 2022 and is projected to grow at 6-8% annually (IQVIA, 2022).
  • Increasing preference for OTC sleep aids expands the potential for stand-alone or combination products.

Innovation areas

  • Natural and organic excipients: Rising consumer demand for "clean label" formulations.
  • Taste-masked liquid formulations: Offering convenience and improved compliance.
  • Sustained-release technologies: Extending sleep duration with proprietary excipient systems.

Strategic partnerships

  • Contract manufacturing organizations (CMOs) with expertise in functional excipients.
  • Ingredient suppliers innovating in biocompatible, plant-based excipients.

Regulatory considerations

  • Excipients must meet pharmacopeia standards (USP, EP).
  • Novel excipients may require additional safety and bioequivalence studies.

How do regulatory requirements shape excipient strategies?

Regulators emphasize the safety profile of excipients, especially in OTC and sleep aid markets.

  • Certain excipients like parabens or sodium benzoate face restrictions due to safety concerns, impacting formulators’ choices.
  • Limitations on excipient quantities are specified in monographs and guidance documents.
  • Innovations in excipient use must undergo safety evaluations and may benefit from accelerated pathways if supported by substantial safety data.

Summary of key features in excipient strategy for night time sleep aids

Feature Details
Focus Stability, quick onset, compliance, safety
Common excipients Diluents, disintegrants, flavoring agents, lubricants
Innovation Natural excipients, controlled-release systems
Market trend OTC expansion, consumer preferences for natural, easy-to-take formulations
Regulatory landscape Emphasizes safety and permissible quantities

Key Takeaways

  • Excipients in night time sleep aids influence stability, efficacy, and patient experience.
  • Formulation strategies favor rapid disintegration, taste masking, and sometimes controlled release.
  • Market growth driven by OTC demand and consumer preferences emphasizes natural, easy-to-administer products.
  • Innovation opportunities include plant-based excipients and specialized release mechanisms.
  • Regulatory standards shape ingredient selection, especially concerning safety and permissible levels.

FAQs

1. What excipients are preferred for quick-onset night time sleep formulations?
Disintegrants like croscellulose sodium and flavoring agents are used to ensure rapid drug release and ease of swallowing.

2. How do natural excipients affect sleep aid formulations?
Natural excipients meet consumer demand for clean-label products but may have challenges related to stability and consistency.

3. Are sustained-release formulations viable for night time sleep aids?
Yes, they extend sleep duration with fewer doses, using excipients like polyethylene oxide. However, safety and precise release control are critical.

4. What regulatory hurdles exist for novel excipients in sleep aids?
New excipients require safety data and compliance with pharmacopeial standards, which can prolong development timelines.

5. How does market growth influence excipient innovation?
The increasing OTC sleep aid market encourages development of innovative, consumer-friendly excipients to differentiate products and meet regulatory and safety standards.


References

[1] IQVIA. (2022). Global Market Report: Sleep Disorders.
[2] U.S. Pharmacopeia. (2022). General Chapters and monographs related to excipients.
[3] European Pharmacopoeia. (2022). Standards for excipient quality and safety.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.